Search
01/01/2025
FACTORS ASSOCIATED WITH CONVERSION OF THE INTERFERON-GAMMA RELEASE ASSAY (IGRA) IN IMMIGRANT CONTACTS OF INDEX CASES WITH PULMONARY TUBERCULOSIS
Godoy, S, Alsedà, M, March-Llanes, J, Parrón, I, Millet, JP, Toledo, D, Caylà, JA, Domínguez, A, Godoy, P. FACTORS ASSOCIATED WITH CONVERSION OF THE INTERFERON-GAMMA RELEASE ASSAY (IGRA) IN IMMIGRANT CONTACTS OF INDEX CASES WITH PULMONARY TUBERCULOSIS. Gaceta Sanitaria. 2025; 39DOI:. PMID:. IF:1.500(Q3/7D).
01/01/2025
A comprehensive GPS-based analysis of activity spaces in early and late pregnancy using the ActMAP framework
Samuelsson, K, Rivas, I, Raimbault, B, Domínguez, A, Galmés, T, Valentin, A, Foraster, M, Gascon, M, Persavento, C, Psyllidis, A, Roig, MDG, Olivé, EL, Nieuwenhuijsen, MJ, Helbich, M, Sunyer, J, Dadvand, P. A comprehensive GPS-based analysis of activity spaces in early and late pregnancy using the ActMAP framework. HEALTH & PLACE. 2025; 91DOI:10.1016/j.healthplace.2025.103413. PMID:39824032. IF:4.100(Q1/2D).
12/02/2024
Angiogenic imbalance in maternal and cord blood is associated with neonatal birthweight and head circumference biometrics in major fetal congenital heart defects.
Sánchez O, Ribera I, Ruiz A, Eixarch E, Antolín E, Cruz-Lemini M, Dominguez C, Arévalo S, Ferrer Q, Rodríguez-Sureda V, Crispi F, Llurba E. Angiogenic imbalance in maternal and cord blood is associated with neonatal birthweight and head circumference biometrics in major fetal congenital heart defects.. ULTRASOUND IN OBSTETRICS & GYNECOLOGY. 2024; 63(2)DOI:10.1002/uog.27441. PMID:37519145. IF:6.300(Q1/1D).
01/12/2023
Mortality and severe neurological morbidity in extremely preterm fetal growth-restricted fetuses.
Mazarico E, Meler E, Mendoza M, Herraiz I, Llurba E, De Diego R, Comas M, Boada D, González A, Bonacina E, Armengol-Alsina M, Moline E, Hurtado I, Torre N, Gomez Roig MD, Galindo A, Figueras F. Mortality and severe neurological morbidity in extremely preterm fetal growth-restricted fetuses.. ULTRASOUND IN OBSTETRICS & GYNECOLOGY. 2023; 62(6)DOI:10.1002/uog.26290. PMID:37325877. IF:(Q/D).
22/07/2023
Bleeding profile and safety of a levonorgestrel 13.5 mg intrauterine device versus Nova T copper 380 mm(2) intrauterine device: Results of a 3-year, single-center, randomized phase 4 study.
Perelló-Capó J, Estadella-Tarriel J, Gich-Saladich I, Bailón-Queiruga M, Llurba-Olivé E, Calaf-Alsina J. Bleeding profile and safety of a levonorgestrel 13.5 mg intrauterine device versus Nova T copper 380 mm(2) intrauterine device: Results of a 3-year, single-center, randomized phase 4 study.. CONTRACEPTION. 2023; 127DOI:10.1016/j.contraception.2023.110127. PMID:37487868. IF:2.800(Q1/3D).
01/02/2022
External validation of prognostic models to predict stillbirth using International Prediction of Pregnancy Complications (IPPIC) Network database: individual participant data meta-analysis
Allotey, J, Whittle, R, Snell, KIE, Smuk, M, Townsend, R, von Dadelszen, P, Heazell, AEP, Magee, L, Smith, GCS, Sandall, J, Thilaganathan, B, Zamora, J, Riley, RD, Khalil, A, Thangaratinam, S, Llurba E., IPPIC Collaborative Network. External validation of prognostic models to predict stillbirth using International Prediction of Pregnancy Complications (IPPIC) Network database: individual participant data meta-analysis. ULTRASOUND IN OBSTETRICS & GYNECOLOGY. 2022; 59(2)DOI:10.1002/uog.23757. PMID:34405928. IF:7.100(Q1/1D).